Rampini Silvana K, Selchow Petra, Keller Christine, Ehlers Stefan, Böttger Erik C, Sander Peter
Institut für Medizinische Mikrobiologie, Universität Zürich, Gloriastrasse 32, CH-8006 Zurich, Switzerland.
Molecular Infection Biology, Research Center Borstel, D-23845 Borstel, Germany.
Microbiology (Reading). 2008 Oct;154(Pt 10):2991-3001. doi: 10.1099/mic.0.2008/018895-0.
The success of Mycobacterium tuberculosis depends on its ability to survive within host macrophages. Here, M. tuberculosis avoids the acidic, hydrolytically competent environment of the phagolysosome by arresting phagosome maturation. Having shown previously that a M. tuberculosis mutant deficient in lipoprotein signal peptidase (LspA) is strongly attenuated in vivo in a mouse model of infection, we now studied putative mechanisms involved in attenuation of the lspA : : aph mutant at a cellular level. In this work we investigated the ability of the mutant to interfere with two host defence mechanisms, i.e. Toll-like receptor (TLR)2-dependent immune response and phagosome maturation. While mycobacterial lipoproteins have been reported to trigger a TLR2 signalling pathway critical for innate immune responses, we found that growth control of the lspA : : aph mutant was independent of TLR2. In addition, the lspA : : aph mutant arrested phagosome maturation to an extent similar to that of the wild-type, as measured by lysosomal-associated membrane protein 1 (LAMP1) co-localization and intraphagosomal pH. These observations demonstrate severe attenuation even in the presence of arrested phagosome maturation, and point to a role for the early phagosome in growth restriction of the M. tuberculosis lspA mutant.
结核分枝杆菌的成功取决于其在宿主巨噬细胞内生存的能力。在此,结核分枝杆菌通过阻止吞噬体成熟来避开吞噬溶酶体的酸性、具有水解活性的环境。先前已表明,脂蛋白信号肽酶(LspA)缺陷的结核分枝杆菌突变体在感染小鼠模型中体内强烈减毒,我们现在在细胞水平研究lspA::aph突变体减毒涉及的假定机制。在这项工作中,我们研究了该突变体干扰两种宿主防御机制的能力,即Toll样受体(TLR)2依赖性免疫反应和吞噬体成熟。虽然据报道分枝杆菌脂蛋白可触发对先天免疫反应至关重要的TLR2信号通路,但我们发现lspA::aph突变体的生长控制与TLR2无关。此外,通过溶酶体相关膜蛋白1(LAMP1)共定位和吞噬体内pH值测量,lspA::aph突变体将吞噬体成熟阻止到与野生型相似的程度。这些观察结果表明,即使在吞噬体成熟受阻的情况下,该突变体也会严重减毒,并表明早期吞噬体在结核分枝杆菌lspA突变体的生长限制中起作用。